| abstract |
The invention relates to an agent for combination therapy, preferably for use in the prophylactic and/or therapeutic treatment of in particular inflammatory diseases of the respiratory tract, particularly bronchopulmonary diseases, or for use in the prophylactic and/or therapeutic treatment of in particular inflammatory diseases of the digestive tract, particularly the intestine. The agent for combination therapy comprises - in particular in active, preferably pharmaceutically active quantities - (a) at least a vitamin D receptor agonist (VDA) and (b) at least a monoterpene. |